SYM Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
SYM Financial's GILD Position: Q3 2026 in Review
SYM Financial increased its Gilead Sciences (GILD) stake by 17% in Q3 2026, buying an estimated $83.1K and bringing the position to 4,057 shares worth $605K. The position accounts for 0.05% of the portfolio, ranked #137.
SYM Financial first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- SYM Financial held 4,057 shares of Gilead Sciences worth $605K as of Q3 2026.
- SYM Financial bought 592 Gilead Sciences shares in Q3 2026, an estimated $83.1K.
- Gilead Sciences made up 0.05% of SYM Financial's portfolio in Q3 2026, its #137 holding.
- SYM Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.